Research

Researchers at leading Neurological and Psychiatric Research Partners around the world
​​​​​​​are using NeuraMetrix TC in their research programs
clinic-research

Validation


NeuraMetrix’s data and research papers from clinical trials for Parkinson’s, Huntington’s, and Depression confirm the device's accuracy and precision. Other neurological diseases and psychiatric disorders are in the process of validation.

Recognition of Superiority


Published article: ‘Monitoring the Motor Phenotype in Huntington’s Disease by Analysis of Keyboard Typing During Real Life Computer Use’

Research Programs


Researchers at leading academic institutions around the world are using NeuraMetrix TC in research programs involving ADHD, Alzheimer's Disease, Bipolar Disorder, Dementia, Depression, Huntington's Disease, Multiple Sclerosis, Neurodegenerative Disease, Parkinson's Disease, REM Sleep Behavior Disorder, Schizophrenia, and Senescence (Biological Aging). We are exploring research relationships for other diseases and disorders.

Concluded

In-process
  • Bipolar Disorder | Karolinska Institute | Sweden
  • Heart problems and Dementia | Boston University | U.S.A.
  • Heart study  | Tulane University | U.S.A.
Planned
  • Alzheimer’s Disease | Boston University | U.S.A.
  • Alzheimer’s Disease (Senescence) | Mayo Clinic | U.S.A.
  • Anxiety | Karolinska Institute | Sweden
  • Depression | Karolinska Institute | Sweden
  • Schizophrenia | Karolinska Institute | Sweden
Written into IRB protocol
  • Parkinson’s Disease | Lund University | Sweden
  • Parkinson’s Disease | Uppsala University | Sweden